This study reveals that CXCR2-mediated neutrophil infiltration and NET formation escalate with pancreatic cancer progression, are enhanced by gemcitabine chemotherapy, contribute to an immunosuppressive microenvironment, and are linked to reduced patient survival. Here, CXCR2 is linked to familial pancreatic carcinoma.